Oxford Biomedica (LON:OXB) Stock Passes Above 200-Day Moving Average – Should You Sell?

Oxford Biomedica plc (LON:OXB)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 391.49 ($4.87) and traded as high as GBX 403 ($5.02). Oxford Biomedica shares last traded at GBX 391 ($4.87), with a volume of 201,486 shares changing hands.

Oxford Biomedica Trading Up 0.6 %

The company has a quick ratio of 1.67, a current ratio of 2.35 and a debt-to-equity ratio of 154.88. The firm’s fifty day moving average is GBX 416.94 and its two-hundred day moving average is GBX 391.49. The firm has a market cap of £414.59 million, a P/E ratio of -273.26 and a beta of 1.09.

Oxford Biomedica Company Profile

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.